The FDA approved brentuximab vedotin (Adcetris) in combination with lenalidomide (Revlimid) and rituximab for relapsed or ...

The FDA has approved acalabrutinib (Calquence, AstraZeneca) with bendamustine and rituximab for patients ... a new generic version of everolimus tablets for oral suspension (Afinitor Disperz ...

Day 90 biopsy data reported from first 3 participants dosed in Phase 1/2 INSPIRE DUCHENNE trial —— Average microdystrophin expression of 110% ...

A new international study has found that a simple tablet treatment could improve survival rates for people with chronic ...

An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) patients with a new all-tablet treatment showing impressive results.

Rituximab, a monoclonal antibody directed against the CD20 molecule found on pre-B cells and mature B cells (but not on plasma cells), was introduced in the late 1990s for the treatment of non ...

The tablets on offer here span from productivity powerhouses to family-friendly devices, and there’s something for a wide range of budgets. Amazon is the place to be for Apple lovers ...

After selling out in barely 48 hours when it launched earlier this month, Lenovo has re-stocked the Legion Tab, its small yet powerful Android tablet. The Lenovo Legion Tab was announced at CES as ...

In December 2024, additional results from the pivotal Phase 3 inMIND trial evaluating treatment with tafasitamab (Monjuvi ®), ...

You’ll find both the Galaxy Tab S9 and S9 FE running Android 14 with the One UI 6 skin on top. This has proven a great software package on the pricier tablets, packing more multitasking features ...

If you want a great Android tablet, you should be shopping for Samsung. My team and I review dozens of tablets every year, and I think Samsung reliably makes some of the best Android slates on the ...

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...